Thrombopoietin
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Thrombopoietin Means in Everyday Medical Language
Thrombopoietin, often called TPO, is a natural protein made by your body, mainly in the liver and kidneys. Its main job is to tell your bone marrow to produce platelets, which are tiny blood cells that help your blood clot and stop bleeding. When your body needs more platelets, thrombopoietin sends signals to immature cells in the bone marrow to grow and mature into platelet-producing cells called megakaryocytes.
Why Thrombopoietin Matters in Cancer Care
Cancer treatments like chemotherapy can lower platelet counts, which increases the risk of bleeding and bruising. Keeping platelet levels healthy is important so patients can safely continue their cancer treatments. Because of this, researchers have studied thrombopoietin and medicines that act like it to help raise platelet counts. These medicines, called thrombopoietin receptor agonists, include drugs like eltrombopag (brand name Promacta) and romiplostim (brand name Nplate). They work by activating the same receptor that thrombopoietin uses to encourage the bone marrow to make more platelets.
What Patients Might See or Hear About Thrombopoietin and Related Medicines
You might hear your care team mention thrombopoietin, TPO, or the names of related drugs like eltrombopag or romiplostim. These terms may appear in your medical records, treatment plans, or lab reports when discussing low platelet counts or treatments to improve them. It’s important to know that seeing these terms does not mean you have a specific diagnosis or that these medicines are automatically part of your care. Instead, they are tools your doctors may consider to help manage low platelets caused by cancer or its treatment.
Common Confusions and How to Understand the Term
Thrombopoietin itself is a natural hormone, while drugs like eltrombopag and romiplostim are medicines designed to mimic its effect. These medicines are sometimes called thrombopoietin receptor agonists because they activate the receptor that thrombopoietin normally binds to. The different names and similar terms can be confusing, so it’s helpful to ask your care team to explain exactly what is being discussed in your case.
How to Read the Term in Context and Next Steps
If you see thrombopoietin or related drug names in your medical information, the best step is to ask your healthcare team what it means for you personally. They can explain whether it relates to your platelet counts, treatment options, or clinical trials. This entry is meant to help you understand the basics but cannot decide what is safe or appropriate for you. Your care team knows your health situation best and can guide you on how thrombopoietin or related medicines might fit into your care.
Sources
Public source information used for this glossary entry includes: